Pesquisas alternativas:
thomas jason » thomas jacob (Expandir a Pesquisa), thomas james (Expandir a Pesquisa), thomas john (Expandir a Pesquisa)
complex tris » complex tric (Expandir a Pesquisa), complex trs (Expandir a Pesquisa), complex traits (Expandir a Pesquisa)
carlos rojek » carlos nojek (Expandir a Pesquisa), carlos rojas (Expandir a Pesquisa), carlos roger (Expandir a Pesquisa)
ift complex » cst complex (Expandir a Pesquisa), joint complex (Expandir a Pesquisa), giant complex (Expandir a Pesquisa)
kno carlos » knopf carlos (Expandir a Pesquisa), cano carlos (Expandir a Pesquisa), nino carlos (Expandir a Pesquisa)
tris ngo » trips ngo (Expandir a Pesquisa), tri ngo (Expandir a Pesquisa), trinh ngo (Expandir a Pesquisa)
nacl kno » nacl nano (Expandir a Pesquisa), nacl en (Expandir a Pesquisa), nacl kcl (Expandir a Pesquisa)
jason n » jason _ (Expandir a Pesquisa), jason a (Expandir a Pesquisa), jason c (Expandir a Pesquisa)
5 ift » _ ift (Expandir a Pesquisa), a ift (Expandir a Pesquisa)
thomas jason » thomas jacob (Expandir a Pesquisa), thomas james (Expandir a Pesquisa), thomas john (Expandir a Pesquisa)
complex tris » complex tric (Expandir a Pesquisa), complex trs (Expandir a Pesquisa), complex traits (Expandir a Pesquisa)
carlos rojek » carlos nojek (Expandir a Pesquisa), carlos rojas (Expandir a Pesquisa), carlos roger (Expandir a Pesquisa)
ift complex » cst complex (Expandir a Pesquisa), joint complex (Expandir a Pesquisa), giant complex (Expandir a Pesquisa)
kno carlos » knopf carlos (Expandir a Pesquisa), cano carlos (Expandir a Pesquisa), nino carlos (Expandir a Pesquisa)
tris ngo » trips ngo (Expandir a Pesquisa), tri ngo (Expandir a Pesquisa), trinh ngo (Expandir a Pesquisa)
nacl kno » nacl nano (Expandir a Pesquisa), nacl en (Expandir a Pesquisa), nacl kcl (Expandir a Pesquisa)
jason n » jason _ (Expandir a Pesquisa), jason a (Expandir a Pesquisa), jason c (Expandir a Pesquisa)
5 ift » _ ift (Expandir a Pesquisa), a ift (Expandir a Pesquisa)
1
Por Lane, Jason W., Rehak, Nadja. N., Hortin, Glen L., Zaoutis, Theoklis, Krause, Philip R., Walsh, Thomas J.
Publicado em 2007
“..., indicating a 0.9 mmol/l Pi increase for every 100 mg/l increase in L-AMB. Ultrafiltration normalized the Pi...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Wright, Jason D., Neugut, Alfred I., Lewin, Sharyn N., Lu, Yu-Shiang, Herzog, Thomas J., Hershman, Dawn L.
Publicado no Obstet Gynecol (2013)
“... from 4.5 in 2000–2001 to 5.4 in 2006–2007 (P=0.10). The percentage of patients treated at the top...”Publicado no Obstet Gynecol (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Olson, KayLoni L., Lillis, Jason, Thomas, J. Graham, Wing, Rena R.
Publicado no Obesity (Silver Spring) (2018)
“....±13.1, BMI: 27±5.5). Average WBIS-M score was 3.0 (±1.3). Study completers (n=862) reported 2.2% (±7.8...”Publicado no Obesity (Silver Spring) (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Boscarino, Joseph A., Logan, Hillary L., Lacny, Jason J., Gallagher, Thomas M.
Publicado em 2008
“... encoding mouse hepatitis coronavirus (MHV) S, E, M, and N (nucleocapsid) into 293T cells and found...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
6
7
Por Lewis, Jason S., Laforest, Richard, Buettner, Thomas L., Song, Sheng-Kwei, Fujibayashi, Yasuhisa, Connett, Judith M., Welch, Michael J.
Publicado em 2001
“... tumors. Radiotherapy experiments were performed in animals bearing either 7-day-old (0.5–1.0 g) or 15-day...”Publicado em 2001
Obter o texto integral
Obter o texto integral
Artigo
8
Por Wright, Jason D., Neugut, Alfred I., Ananth, Cande V., Lewin, Sharyn N., Wilde, Elizabeth T., Lu, Yu-Shiang, Herzog, Thomas J., Hershman, Dawn L.
Publicado em 2013
“... likely to receive guideline-based antibiotics (p<0.05). Vancomycin use increased from 17% in 2000 to 55...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Wright, Jason D., Ananth, Cande V., Ojalvo, Laureen, Herzog, Thomas J., Lewin, Sharyn N., Lu, Yu-Shiang, Neugut, Alfred I., Hershman, Dawn L.
Publicado em 2013
“... from 0—1.12%. The complication rate was 6.5% at the hospitals with the lowest mortality rates, 9.9...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Wright, Jason D., Herzog, Thomas J., Tsui, Jennifer, Ananth, Cande V., Lewin, Sharyn N., Lu, Yu-Shiang, Neugut, Alfred I., Hershman, Dawn L.
Publicado em 2013
“... of the following indications declined: leiomyoma (−47.6%), abnormal bleeding (−28.9%), benign ovarian mass (−63.1...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Wright, Jason D., Ananth, Cande V., Lewin, Sharyn N., Burke, William M., Siddiq, Zainab, Neugut, Alfred I., Herzog, Thomas J., Hershman, Dawn L.
Publicado no J Surg Res (2013)
“..., hemostatic agents were used in 30.3% (n=1,102,267). The use of hemostatic agents increased from 28.5% in 2000...”Publicado no J Surg Res (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Hardy, Chris J. D., Agustus, Jennifer L., Marshall, Charles R., Clark, Camilla N., Russell, Lucy L., Bond, Rebecca L., Brotherhood, Emilie V., Thomas, David L., Crutch, Sebastian J., Rohrer, Jonathan D., Warren, Jason D.
Publicado no Alzheimers Res Ther (2017)
Obter o texto integralPublicado no Alzheimers Res Ther (2017)
Obter o texto integral
Obter o texto integral
Artigo
13
Por Wright, Jason D., Deutsch, Israel, Wilde, Elizabeth T., Ananth, Cande V., Neugut, Alfred I., Lewin, Sharyn N., Siddiq, Zainab, Herzog, Thomas J., Hershman, Dawn L.
Publicado em 2013
“... identified a total of 3555 patients including 328 (9.2%) who received IMRT. Use of IMRT increased from 1.5...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por George, Erin M., Herzog, Thomas J., Neugut, Alfred I., Lu, Yu-Shiang, Burke, William M., Lewin, Sharyn N., Hershman, Dawn L., Wright, Jason D.
Publicado no Gynecol Oncol (2013)
“... carcinosarcomas was 65.2% (95% CI, 58.0-71.4%) vs. 80.6% (95% CI, 78.9-82.2%) for serous tumors. Similarly, five...”Publicado no Gynecol Oncol (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“... the zebrafish nicotinic acetylcholine receptor (nAChR) subunits and expressed key nAChR subtypes in Xenopus...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Polcin, Douglas L., Korcha, Rachael, Greenfield, Thomas K., Bond, Jason, Kerr, William
Publicado em 2011
“... Surveys (NAS) collected at approximately five-year intervals over a 21 year period (1984 to 2005, pooled N...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Korcha, Rachael A., Polcin, Douglas L., Kerr, William, Greenfield, Thomas, Bond, Jason
Publicado em 2012
“...: Current drinkers from the National Alcohol Surveys (NAS) from 1984-2005 (N=16,183) were used to describe...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por de Mattos-Shipley, Kate M. J., Greco, Claudio, Heard, David M., Hough, Gemma, Mulholland, Nicholas P., Vincent, Jason L., Micklefield, Jason, Simpson, Thomas J., Willis, Christine L., Cox, Russell J., Bailey, Andrew M.
Publicado no Chem Sci (2018)
“... that the cycloaspeptide gene cluster contains a minimal 5-module nonribosomal peptide synthetase (NRPS) and a new type...”Publicado no Chem Sci (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Ashford, Jason M., Netson, Kelli L., Clark, Kellie N., Merchant, Thomas E., Santana, Victor M., Wu, Shengjie, Conklin, Heather M.
Publicado em 2014
“...) were BT survivors treated with conformal radiation therapy (n=50), healthy siblings of BT survivors (n...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Galic, Vijaya, Schiavone, Maria B., Herzog, Thomas J., Holcomb, Kevin, Lewin, Sharyn N., Lu, Yu-Shiang, Neugut, Alfred I., Hershman, Dawn L., Wright, Jason D.
Publicado no Cancer Invest (2013)
“... was 0.95 (95% CI, 0.85-1.07). Five-year survival for stage I mucinous tumors was 89.9% (95% CI, 87.6-91.9...”Publicado no Cancer Invest (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo